Literature DB >> 12563260

Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function.

Amy N Anzelon1, Hong Wu, Robert C Rickert.   

Abstract

Phosphoinositide 3-kinase (PI3K) and phosphatase and tensin homolog (PTEN) phosphatase serve essential functions in the regulation of cell growth, differentiation and survival by modulating intracellular phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) concentrations. Here we show that the conditional deletion of Pten in B cells led to the preferential generation of marginal zone (MZ) B cells and B1 cells. PTEN-deficient B cells were hyperproliferative in response to mitogenic stimuli, and exhibited a lower threshold for activation through the B cell antigen receptor. Inactivation of PTEN rescued germinal center, MZ B and B1 cell formation in CD19-/- mice, arguing that recruitment and activation of PI3K are the dominant roles for CD19 in these B cell subpopulations. These findings establish the central role of PI-3,4,5-P3 regulation in the differentiation of peripheral B cell subsets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563260     DOI: 10.1038/ni892

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  88 in total

1.  N-Glycan Branching Is Required for Development of Mature B Cells.

Authors:  Christie-Lynn Mortales; Sung-Uk Lee; Michael Demetriou
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

Review 2.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

3.  Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells.

Authors:  J L Moody; F R Jirik
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 4.  Control systems and decision making for antibody production.

Authors:  Christopher C Goodnow; Carola G Vinuesa; Katrina L Randall; Fabienne Mackay; Robert Brink
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

5.  CD19 controls Toll-like receptor 9 responses in human B cells.

Authors:  Henner Morbach; Jean-Nicolas Schickel; Charlotte Cunningham-Rundles; Mary Ellen Conley; Ismail Reisli; Jose Luis Franco; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

Review 6.  Functional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation.

Authors:  Maoyi Lai; Changchun Xiao
Journal:  Int Immunopharmacol       Date:  2015-04-11       Impact factor: 4.932

7.  IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8α+ Dendritic Cells Promotes Listeria monocytogenes Infection.

Authors:  Dong Liu; Xiangyun Yin; Sam J Olyha; Manuela Sales L Nascimento; Pei Chen; Theresa White; Uthaman Gowthaman; Tingting Zhang; Jake A Gertie; Biyan Zhang; Lan Xu; Marina Yurieva; Lesley Devine; Adam Williams; Stephanie C Eisenbarth
Journal:  Immunity       Date:  2019-06-20       Impact factor: 31.745

8.  Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection.

Authors:  Laurent Verkoczy; Bao Duong; Patrick Skog; Djemel Aït-Azzouzene; Kamal Puri; José Luis Vela; David Nemazee
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

9.  The role of the PI3K-AKT kinase pathway in T-cell development beyond the beta checkpoint.

Authors:  Ling Xue; Leslie Chiang; Chulho Kang; Astar Winoto
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

10.  PTEN regulates natural killer cell trafficking in vivo.

Authors:  Jeffrey W Leong; Stephanie E Schneider; Ryan P Sullivan; Bijal A Parikh; Bryan A Anthony; Anvita Singh; Brea A Jewell; Timothy Schappe; Julia A Wagner; Daniel C Link; Wayne M Yokoyama; Todd A Fehniger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.